Skip to main content
S 1692 117th Congress Senate Health Aging Congressional oversight Health care costs and insurance Health care quality Health information and medical records Health promotion and preventive care Medical tests and diagnostic methods Medicare Neurological disorders

Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021

Introduced: May 19, 2021 Introduced by: Capito, Shelley Moore Republican · West Virginia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 19, 2021
Read twice and referred to the Committee on Finance.
May 19, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2021

This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.

Additionally, the Centers for Medicare & Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.

What's happening now May 19, 2021

Read twice and referred to the Committee on Finance.

 Related & companion bills 1
  • HR 3354 Related bill CHANGE Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 11
All 11 Democratic 5 Republican 4 Independent 1
D
Peters, Gary C.
Michigan · Sep 12, 2022
 D
Blumenthal, Richard
Connecticut · Jun 9, 2022
 I
King, Angus S., Jr.
Maine · Jun 9, 2022
 D
Klobuchar, Amy
Minnesota · Jun 9, 2022
 D
Shaheen, Jeanne
New Hampshire · Jun 9, 2022
 R
Tillis, Thomas
North Carolina · Dec 16, 2021
 D
Van Hollen, Chris
Maryland · Dec 16, 2021
 R
Hoeven, John
North Dakota · Oct 21, 2021
Sinema, Kyrsten
· Oct 21, 2021
 R
Hyde-Smith, Cindy
Mississippi · Jul 14, 2021
 R
Wicker, Roger F.
Mississippi · May 19, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1692: Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-1692/
MLA
"S. 1692: Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1692/.
Bluebook (legal)
S. 1692, 117th Cong. (2026), https://openamerica.io/bill/117-S-1692/.
Markdown link
[S. 1692: Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021](https://openamerica.io/bill/117-S-1692/)
Report a problem